Trk receptors are a family of three receptor tyrosine kinases (TrkA, TrkB, and TrkC), each of which can be activated by one or more of the four neurotrophins nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophins 3 and 4 (NT3 and NT4).
The TRK receptor family is made up of the transmembrane proteins TrkA, TrkB, and TrkC. These receptor tyrosine kinases are expressed in human neuronal tissue and are crucial for the physiology of nervous system development and function. Neurotrophins (NTs) activate these receptor tyrosine kinases. For TrkA, BDGF, NT-4/5, and TrkB and TrkC, respectively, these latter substances are specific ligands known as NGF and NT-3.
When a ligand binds to a receptor, the receptors begin to oligomerize and certain tyrosine residues in the intracytoplasmic kinase domain become phosphorylated. As a result of this action, signal transduction pathways that promote proliferation, differentiation, and survival in both healthy and malignant neuronal cells are activated.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V76394 | TrkA-IN-4 | TrkA-IN-4 is a potent and orally bioactive allosteric inhibitor of TrkA and the precursor of TrkA-IN-3. | |
|
V81624 | TrkA-IN-6 | TrkA-IN-6 (compound R48) is a hydrazone, selective inhibitor of tropomyosin kinase type A receptor kinase (TrkA). | |
|
V69598 | TrkB-IN-1 | 1609067-49-3 | TrkB-IN-1 is a potent orally bioactive TrkB agonist/activator with good pharmacokinetic properties. |
|
V69593 | Type II TRK inhibitor 1 | 2937543-72-9 | Type II TRK?inhibitor 1 is a potent TRK inhibitor that can suppress various TRK fusion protein variants and wild type. |
|
V78315 | Type II TRK inhibitor 2 | Type II TRK inhibitor 2 (compound 40l) is a selective type II TRK inhibitor (antagonist) with plasma stability and moderate hepatic microsomal stability. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
